Establishing a bone marrow stromal cell transplant program at the National Institutes of Health Clinical Center
- PMID: 24368014
- PMCID: PMC4030651
- DOI: 10.1089/ten.TEB.2013.0529
Establishing a bone marrow stromal cell transplant program at the National Institutes of Health Clinical Center
Abstract
A repository of cryopreserved bone marrow stromal cell (BMSC) products prepared from marrow aspirates of healthy subjects has been created and is being used to treat patients with inflammatory bowel disease, cardiovascular disease, and acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. New methods of manufacturing BMSCs are being investigated including the use of an automated bioreactor for BMSC expansion and the replacement of fetal bovine serum with human platelet lysate as a media supplement. Efforts are also being made to identify markers that can be used to assess the potency of BMSCs.
References
-
- Krebsbach P.H., Mankani M.H., Satomura K., Kuznetsov S.A., and Robey P.G.Repair of craniotomy defects using bone marrow stromal cells. Transplantation 66,1272, 1998 - PubMed
-
- Bruder S.P., Kurth A.A., Shea M., Hayes W.C., Jaiswal N., and Kadiyala S.Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J Orthop Res 16,155, 1998 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources